Answers are grounded in this paper and cite their sources.
According to the clinical assessment, 85–95% of patients undergoing standard radiation therapy develop such a side effect of radiation dermatitis (RD). Currently, the study of the problem of RD moves away from the classification of the main symptoms towards the development of high-tech methods of diagnosis and treatment, which are associated with the use of bioactive substances of different nature, targeted and cellular therapy, and also nanotechnology. However, there is currently no worldwide standard treatment for RD. This review presents a retrospective of the formation and development of this problem, the current state and possible ways of further development of studies.
No takes yet. Share an insight, caveat, or question.
Сорокина et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: